Publications:

---

Ado-tratuzumab emtansine beyond breast cancer: therapeutic role of targeting other HER2-positive cancers.

Frontiers In Molecular Biosciences

Zheng, Yang Y; Zou, Jiayu J; Sun, Chen C; Peng, Fu F; Peng, Cheng C

Publication Date: 2023

Variant appearance in text: HER2: V659E

PubMed Link: 37251081

Variant Present in the following documents:

• Main text
• fmolb-10-1165781.pdf

View BVdb publication page

---

The Role of HER2 Status in the Biliary Tract Cancers.

Cancers

Ayasun, Ruveyda R; Ozer, Muhammet M; Sahin, Ilyas I

Publication Date: 2023-05-05

Variant appearance in text: HER2: V659E

PubMed Link: 37174094

Variant Present in the following documents:

• Main text
• cancers-15-02628.pdf

View BVdb publication page

---

Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer.

Frontiers In Oncology

Han, Yanjie Y; Xiong, Yuanyuan Y; Lu, Tao T; Chen, Rongrong R; Liu, Yuan Y; Tang, Hui H; Geng, Ruixuan R; Wang, Yingyi Y

Publication Date: 2023

Variant appearance in text: HER2: V659E

PubMed Link: 37077822

Variant Present in the following documents:

• Main text
• fonc-13-1121708.pdf

View BVdb publication page

---

Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.

Nature Communications

Harding, James J JJ; Piha-Paul, Sarina A SA; Shah, Ronak H RH; Murphy, Jessica J JJ; Cleary, James M JM; Shapiro, Geoffrey I GI; Quinn, David I DI; Braña, Irene I; Moreno, Victor V; Borad, Mitesh M; Loi, Sherene S; Spanggaard, Iben I; Park, Haeseong H; Ford, James M JM; Arnedos, Mónica M; Stemmer, Salomon M SM; de la Fouchardiere, Christelle C; Fountzilas, Christos C; Zhang, Jie J; DiPrimeo, Daniel D; Savin, Casey C; Duygu Selcuklu, S S; Berger, Michael F MF; Eli, Lisa D LD; Meric-Bernstam, Funda F; Jhaveri, Komal K; Solit, David B DB; Abou-Alfa, Ghassan K GK

Publication Date: 2023-02-06

Variant appearance in text: ERBB2: V659E

PubMed Link: 36746967

Variant Present in the following documents:

• Main text
• 41467_2023_36399_MOESM1_ESM.pdf
• 41467_2023_Article_36399.pdf
• 41467_2023_36399_MOESM3_ESM.xlsx, sheet 5

View BVdb publication page

---

An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.

Frontiers In Immunology

Lin, Jing J; Liu, Jun J; Hao, Shi-Guang SG; Lan, Bin B; Zheng, Xiao-Bin XB; Xiong, Jia-Ni JN; Zhang, Ying-Qian YQ; Gao, Xuan X; Chen, Chuan-Ben CB; Chen, Ling L; Huang, Yu-Fang YF; Luo, Hong H; Yi, Yu-Ting YT; Yi, Xin X; Lu, Jian-Ping JP; Zheng, Xiong-Wei XW; Chen, Gang G; Wang, Xue-Feng XF; Chen, Yu Y

Publication Date: 2022

Variant appearance in text: ERBB2: 1976_1977delTTinsAG; V659E

PubMed Link: 36505399

Variant Present in the following documents:

• Table_2.xlsx, sheet 3
• Table_2.xlsx, sheet 2

View BVdb publication page

---

Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer.

Thoracic Cancer

Zhang, Shirong S; Wang, Wenxian W; Xu, Chunwei C; Zhang, Yongchang Y; Cai, Xiuyu X; Wang, Qian Q; Song, Zhengbo Z; Li, Ziming Z; Yu, Jinpu J; Zhong, Wenzhao W; Wang, Zhijie Z; Liu, Jingjing J; Liu, Anwen A; Li, Wen W; Zhan, Ping P; Liu, Hongbing H; Lv, Tangfeng T; Miao, Liyun L; Min, Lingfeng L; Lin, Gen G; Huang, Long L; Yuan, Jingping J; Jiang, Zhansheng Z; Pu, Xingxiang X; Rao, Chuangzhou C; Lv, Dongqing D; Yu, Zongyang Z; Li, Xiaoyan X; Tang, Chuanhao C; Zhou, Chengzhi C; Zhang, Junping J; Guo, Hui H; Chu, Qian Q; Meng, Rui R; Liu, Xuewen X; Wu, Jingxun J; Zhou, Jin J; Zhu, Zhengfei Z; Pan, Weiwei W; Dong, Xiaowei X; Pang, Fei F; Wang, Kai K; Yao, Chao C; Lin, Guomin G; Li, Site S; Yang, Zhi Z; Luo, Jiancheng J; Jia, Hongtao H; Nie, Xiuqing X; Wang, Liping L; Zhu, Youcai Y; Hu, Xiao X; Xie, Yanru Y; Lin, Xinqing X; Cai, Jing J; Xia, Yang Y; Feng, Huijing H; Wang, Lin L; Du, Yingying Y; Yao, Wang W; Shi, Xuefei X; Niu, Xiaomin X; Yuan, Dongmei D; Yao, Yanwen Y; Kang, Jing J; Zhang, Jiatao J; Zhang, Chao C; Gao, Wenbin W; Huang, Jianhui J; Zhang, Yinbin Y; Sun, Pingli P; Wang, Hong H; Ye, Mingxiang M; Wang, Dong D; Wang, Zhaofeng Z; Wan, Bing B; Lv, Donglai D; Yu, Genhua G; Shi, Lin L; Xia, Yuanli Y; Gao, Feng F; Zhang, Xiaochen X; Xu, Tao T; Zhou, Wei W; Wang, Haixia H; Liu, Zhefeng Z; Yang, Nong N; Wu, Lin L; Wang, Qiming Q; Wang, Guansong G; Hong, Zhuan Z; Wang, Jiandong J; Fang, Meiyu M; Fang, Yong Y; Zhang, Yiping Y; Song, Yong Y; Ma, Shenglin S; Fang, Wenfeng W; Lu, Yuanzhi Y

Publication Date: 2022-11-28

Variant appearance in text: HER2: V659E

PubMed Link: 36444143

Variant Present in the following documents:

• Main text
• TCA-14-91.pdf

View BVdb publication page

---

Real World Characteristics and Clinical Outcomes of HER2-Mutant Non-Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing.

Cancer Research And Treatment

Ahn, Beung-Chul BC; Han, Ye-Jeong YJ; Kim, Hye Ryun HR; Hong, Min Hee MH; Cho, Byoung Chul BC; Lim, Sun Min SM

Publication Date: 2022-11-09

Variant appearance in text: HER2: V659E

PubMed Link: 36397236

Variant Present in the following documents:

• Main text
• crt-2022-359.pdf

View BVdb publication page

---

Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers.

Bmc Cancer

Wu, Huita H; Ji, Haonan H; Yang, Wenhui W; Zhang, Min M; Guo, Yifang Y; Li, Bangkai B; Wang, Jiayin J; Chen, Rongrong R; Chen, Yuan Y; Wang, Xin X

Publication Date: 2022-09-27

Variant appearance in text: ERBB2: V659E

PubMed Link: 36167530

Variant Present in the following documents:

• 12885_2022_9922_MOESM5_ESM.xlsx, sheet 1

View BVdb publication page

---

Identification of Activating Mutations in the Transmembrane and Extracellular Domains of EGFR.

Biochemistry

Wagner, Anja A; Galicia-Andrés, Edgar E; Teufl, Magdalena M; Gold, Lukas L; Obinger, Christian C; Sykacek, Peter P; Oostenbrink, Chris C; Traxlmayr, Michael W MW

Publication Date: 2022-10-04

Variant appearance in text: HER2: V659E

PubMed Link: 36148499

Variant Present in the following documents:

• bi2c00384.pdf

View BVdb publication page

---

Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors.

Pathology Oncology Research : Por

Wang, Hao H; Miao, Ji J; Wen, Yazhou Y; Xia, Xihua X; Chen, Yanan Y; Huang, Mengli M; Chen, Shiqing S; Zhao, Zhengyi Z; Zhang, Yuzi Y; Chen, Chunzhu C; Zhu, Xinhua X

Publication Date: 2022

Variant appearance in text: ERBB2: V659E

PubMed Link: 35911441

Variant Present in the following documents:

• Main text
• pore-28-1610360.pdf

View BVdb publication page

---

Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.

Ebiomedicine

Zuo, Ying Y; Zhong, Jia J; Bai, Hua H; Xu, Bin B; Wang, Zhijie Z; Li, Weihua W; Chen, Yedan Y; Jin, Shi S; Wang, Shuhang S; Wang, Xin X; Wan, Rui R; Xu, Jiachen J; Fei, Kailun K; Han, Jiefei J; Yang, Zhenlin Z; Bao, Hua H; Shao, Yang Y; Ying, Jianming J; Song, Qibin Q; Duan, Jianchun J; Wang, Jie J

Publication Date: 2022-08

Variant appearance in text: ERBB2: V659E

PubMed Link: 35901658

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page

---

Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.

Aging

Su, Xiaofan X; Jin, Haoxuan H; Wang, Jiaqian J; Lu, Huiping H; Gu, Tiantian T; Gao, Zhibo Z; Li, Manxiang M

Publication Date: 2022-05-25

Variant appearance in text: ERBB2: 1976_1977delTTinsAG; V659E

PubMed Link: 35613927

Variant Present in the following documents:

• aging-14-204101-s004.xlsx, sheet 1

View BVdb publication page

---

Clinical and genomic features of Chinese lung cancer patients with germline mutations.

Nature Communications

Peng, Wenying W; Li, Bin B; Li, Jin J; Chang, Lianpeng L; Bai, Jing J; Yi, Yuting Y; Chen, Rongrong R; Zhang, Yanyan Y; Chen, Chen C; Pu, Xingxiang X; Jiang, Meilin M; Li, Jia J; Zhong, Rui R; Xu, Fang F; Chen, Bolin B; Xu, Li L; Wang, Ning N; Huan, Jiaojiao J; Dai, Pingping P; Guan, Yanfang Y; Yang, Ling L; Xia, Xuefeng X; Yi, Xin X; Wang, Jiayin J; Yu, Fenglei F; Wu, Lin L

Publication Date: 2022-03-10

Variant appearance in text: ERBB2: 1976_1977delTTinsAG; V659E

PubMed Link: 35273153

Variant Present in the following documents:

• 41467_2022_28840_MOESM7_ESM.xlsx, sheet 1

View BVdb publication page

---

Systematic review and meta-analysis of genomic alterations in acral melanoma.

Pigment Cell & Melanoma Research

Broit, Natasa N; Johansson, Peter A PA; Rodgers, Chloe B CB; Walpole, Sebastian T ST; Hayward, Nicholas K NK; Pritchard, Antonia L AL

Publication Date: 2022-05

Variant appearance in text: ERBB2: V659E

PubMed Link: 35229492

Variant Present in the following documents:

• PCMR-35-369-s003.xlsx, sheet 12

View BVdb publication page

---

The efficacy of afatinib in patients with HER2 mutant non-small cell lung cancer: a meta-analysis.

Translational Cancer Research

Zhou, Niya N; Zhao, Jie J; Huang, Xiu X; Shen, Hui H; Li, Wen W; Xu, Zhihao Z; Xia, Yang Y

Publication Date: 2020-05

Variant appearance in text: HER2: V659E

PubMed Link: 35117726

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial.

Bmc Medicine

Song, Zhengbo Z; Li, Yuping Y; Chen, Shiqing S; Ying, Shenpeng S; Xu, Shuguang S; Huang, Jianjin J; Wu, Dan D; Lv, Dongqing D; Bei, Ting T; Liu, Shuxun S; Huang, Xiaoping X; Xie, Congying C; Wu, Xiaoyu X; Fu, Jianfei J; Hua, Feng F; Wang, Wenxian W; Xu, Chunwei C; Gao, Chan C; Cai, Shangli S; Lu, Shun S; Zhang, Yiping Y

Publication Date: 2022-02-01

Variant appearance in text: HER2: V659E

PubMed Link: 35101045

Variant Present in the following documents:

• Main text
• 12916_2022_Article_2245.pdf

View BVdb publication page

---

Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial.

Bmc Medicine

Song, Zhengbo Z; Li, Yuping Y; Chen, Shiqing S; Ying, Shenpeng S; Xu, Shuguang S; Huang, Jianjin J; Wu, Dan D; Lv, Dongqing D; Bei, Ting T; Liu, Shuxun S; Huang, Xiaoping X; Xie, Congying C; Wu, Xiaoyu X; Fu, Jianfei J; Hua, Feng F; Wang, Wenxian W; Xu, Chunwei C; Gao, Chan C; Cai, Shangli S; Lu, Shun S; Zhang, Yiping Y

Publication Date: 2022-02-01

Variant appearance in text: HER2: V659E

PubMed Link: 35101045

Variant Present in the following documents:

• Main text
• 12916_2022_Article_2245.pdf

View BVdb publication page

---

HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy.

Pharmaceuticals (Basel, Switzerland)

Vathiotis, Ioannis A IA; Charpidou, Andriani A; Gavrielatou, Niki N; Syrigos, Konstantinos N KN

Publication Date: 2021-12-14

Variant appearance in text: HER2: V659E

PubMed Link: 34959700

Variant Present in the following documents:

• Main text
• pharmaceuticals-14-01300.pdf

View BVdb publication page

---

HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy.

Pharmaceuticals (Basel, Switzerland)

Vathiotis, Ioannis A IA; Charpidou, Andriani A; Gavrielatou, Niki N; Syrigos, Konstantinos N KN

Publication Date: 2021-12-14

Variant appearance in text: HER2: V659E

PubMed Link: 34959700

Variant Present in the following documents:

• Main text
• pharmaceuticals-14-01300.pdf

View BVdb publication page

---

Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.

Journal For Immunotherapy Of Cancer

Hu, Chunhong C; Zhao, Lishu L; Liu, Wenliang W; Fan, Songqing S; Liu, Junqi J; Liu, Yuxuan Y; Liu, Xiaohan X; Shu, Long L; Liu, Xianling X; Liu, Ping P; Deng, Chao C; Qiu, Zhenhua Z; Chen, Chen C; Jiang, Yi Y; Liang, Qingchun Q; Yang, Lingling L; Shao, Yang Y; He, Qiongzhi Q; Yu, Danlei D; Zeng, Yue Y; Li, Yizheng Y; Pan, Yue Y; Zhang, Sujuan S; Shi, Shenghao S; Peng, Yurong Y; Wu, Fang F

Publication Date: 2021-12

Variant appearance in text: ERBB2: V659E

PubMed Link: 34887263

Variant Present in the following documents:

• jitc-2021-003773supp001.pdf

View BVdb publication page

---

Afatinib combined with anlotinib in the treatment of lung adenocarcinoma patient with novel HER2 mutation: a case report and review of the literature.

World Journal Of Surgical Oncology

Xu, Huanhuan H; Liang, Qi Q; Xu, Xian X; Tan, Shanyue S; Wang, Sumeng S; Liu, Yiqian Y; Liu, Lingxiang L

Publication Date: 2021-11-18

Variant appearance in text: HER2: V659E

PubMed Link: 34794435

Variant Present in the following documents:

• Main text
• 12957_2021_Article_2444.pdf

View BVdb publication page

---

Human Erbb2-induced Erk activity robustly stimulates cycling and functional remodeling of rat and human cardiomyocytes.

Elife

Strash, Nicholas N; DeLuca, Sophia S; Janer Carattini, Geovanni L GL; Heo, Soon Chul SC; Gorsuch, Ryne R; Bursac, Nenad N

Publication Date: 2021-10-19

Variant appearance in text: HER2: V659E

PubMed Link: 34665129

Variant Present in the following documents:

• Main text
• elife-65512.pdf

View BVdb publication page

---

Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology

Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C

Publication Date: 2021

Variant appearance in text: ERBB2: V659E

PubMed Link: 34630336

Variant Present in the following documents:

• Table_1.xlsx, sheet 2

View BVdb publication page

---

Activity and mechanism of acquired resistance to tarloxotinib in HER2 mutant lung cancer: an in vitro study.

Translational Lung Cancer Research

Koga, Takamasa T; Suda, Kenichi K; Nishino, Masaya M; Fujino, Toshio T; Ohara, Shuta S; Hamada, Akira A; Soh, Junichi J; Tirunagaru, Vijaya V; Vellanki, Avanish A; Doebele, Robert C RC; Mitsudomi, Tetsuya T

Publication Date: 2021-08

Variant appearance in text: HER2: V659E

PubMed Link: 34584864

Variant Present in the following documents:

• Main text
• tlcr-10-08-3659-supplementary.pdf
• tlcr-10-08-3659.pdf

View BVdb publication page

---

DEVOLUTION-A method for phylogenetic reconstruction of aneuploid cancers based on multiregional genotyping data.

Communications Biology

Andersson, Natalie N; Chattopadhyay, Subhayan S; Valind, Anders A; Karlsson, Jenny J; Gisselsson, David D

Publication Date: 2021-09-20

Variant appearance in text: ERBB2: V659E

PubMed Link: 34545199

Variant Present in the following documents:

• 42003_2021_2637_MOESM2_ESM.pdf

View BVdb publication page

---

Clinicopathological Features and Survival Outcomes of Primary Pulmonary Invasive Mucinous Adenocarcinoma.

Cancers

Gow, Chien-Hung CH; Hsieh, Min-Shu MS; Liu, Yi-Nan YN; Lee, Yi-Hsuan YH; Shih, Jin-Yuan JY

Publication Date: 2021-08-15

Variant appearance in text: HER2: V659E

PubMed Link: 34439256

Variant Present in the following documents:

• Main text

View BVdb publication page

---

HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy.

Cells

De Giovanni, Carla C; Landuzzi, Lorena L; Palladini, Arianna A; Nicoletti, Giordano G; Nanni, Patrizia P; Lollini, Pier-Luigi PL

Publication Date: 2021-07-16

Variant appearance in text: HER2: V659E

PubMed Link: 34359977

Variant Present in the following documents:

• Main text
• cells-10-01808.pdf

View BVdb publication page

---

2021 ACVIM Forum Research Abstract Program.

Journal Of Veterinary Internal Medicine

Publication Date: 2021-08-05

Variant appearance in text: ERBB2: V659E

PubMed Link: 34351021

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Progress in Treatment of Non-Small Cell Lung Cancer Harboring HER2 Aberrations.

Oncotargets And Therapy

Ni, Jun J; Zhang, Li L

Publication Date: 2021

Variant appearance in text: HER2: V659E

PubMed Link: 34262294

Variant Present in the following documents:

• Main text

View BVdb publication page

---

The Presence of Genomic Instability in Cerebrospinal Fluid in Patients with Meningeal Metastasis.

Cancer Management And Research

Wang, Peng P; Zhang, Henghui H; Chen, Peng P; Sun, Zengfeng Z; Zhang, Zhen Z; Yin, Qiang Q; Sun, Huaibo H; Yu, Jinpu J

Publication Date: 2021

Variant appearance in text: ERBB2: V659E

PubMed Link: 34188538

Variant Present in the following documents:

• Main text
• cmar-13-4853.pdf

View BVdb publication page

---

Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study.

Frontiers In Oncology

Song, Zhengbo Z; Lv, Dongqing D; Chen, Shiqing S; Huang, Jianhui J; Wang, Liping L; Xu, Shuguang S; Chen, Huafei H; Wang, Guoqiang G; Lin, Quan Q

Publication Date: 2021

Variant appearance in text: HER2: V659E

PubMed Link: 34026634

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy.

Molecular Therapy Oncolytics

Meng, Jialin J; Lu, Xiaofan X; Zhou, Yujie Y; Zhang, Meng M; Ge, Qintao Q; Zhou, Jun J; Hao, Zongyao Z; Gao, Shenglin S; Yan, Fangrong F; Liang, Chaozhao C

Publication Date: 2021-03-26

Variant appearance in text: ERBB2: V659E

PubMed Link: 33665361

Variant Present in the following documents:

• Main text
• mmc4.pdf
• main.pdf

View BVdb publication page

---

Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards.

Esmo Open

Danesi, R R; Fogli, S S; Indraccolo, S S; Del Re, M M; Dei Tos, A P AP; Leoncini, L L; Antonuzzo, L L; Bonanno, L L; Guarneri, V V; Pierini, A A; Amunni, G G; Conte, P P

Publication Date: 2021-04

Variant appearance in text: HER2: V659E

PubMed Link: 33540286

Variant Present in the following documents:

• Main text

View BVdb publication page

---

[Research Progress of Targeted Therapy for HER2 Gene 
in Advanced Non-small Cell Lung Cancer].

Zhongguo Fei Ai Za Zhi = Chinese Journal Of Lung Cancer

Kong, Lingping L; Zhong, Diansheng D

Publication Date: 2020-12-20

Variant appearance in text: HER2: V659E

PubMed Link: 33357319

Variant Present in the following documents:

• Main text
• zgfazz-23-12-1108.pdf

View BVdb publication page

---

Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m6A Methylation.

Molecular Cell

Sun, Hui-Lung HL; Zhu, Allen C AC; Gao, Yawei Y; Terajima, Hideki H; Fei, Qili Q; Liu, Shun S; Zhang, Linda L; Zhang, Zijie Z; Harada, Bryan T BT; He, Yu-Ying YY; Bissonnette, Marc B MB; Hung, Mien-Chie MC; He, Chuan C

Publication Date: 2020-11-19

Variant appearance in text: HER2: V659E

PubMed Link: 33217317

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Clinical significance of ERBB2 exon 16 skipping: analysis of a real-world retrospective observational cohort study.

Esmo Open

Shi, Lei L; Xu, Caihua C; Ma, Yutong Y; Ou, Qiuxiang Q; Wu, Xue X; Lu, Songhua S; Shao, Yang Y; Guo, Renhua R; Kong, Jinliang J

Publication Date: 2020-11

Variant appearance in text: ERBB2: V659E

PubMed Link: 33214226

Variant Present in the following documents:

• Main text
• esmoopen-2020-000985.pdf

View BVdb publication page

---

Clinical outcomes of patients with HER2-mutant advanced lung cancer: chemotherapies versus HER2-directed therapies.

Therapeutic Advances In Medical Oncology

Zhou, Jiebai J; Ding, Ning N; Xu, Xiaobo X; Zhang, Yong Y; Ye, Maosong M; Li, Chun C; Hu, Jie J

Publication Date: 2020

Variant appearance in text: HER2: V659E

PubMed Link: 32647540

Variant Present in the following documents:

• 10.1177_1758835920936090.pdf

View BVdb publication page

---

Clinical and molecular characteristics of Chinese non-small cell lung cancer patients with ERBB2 transmembrane domain mutations.

Molecular Oncology

Fan, Yun Y; Qiu, Jinrong J; Yu, Ruoying R; Cao, Ran R; Chen, Xiaoxi X; Ou, Qiuxiang Q; Wu, Xue X; Shao, Yang W YW; Nagasaka, Misako M; Zhang, Jiexia J; Ou, Sai-Hong Ignatius SI

Publication Date: 2020-08

Variant appearance in text: ERBB2: V659E

PubMed Link: 32478891

Variant Present in the following documents:

• Main text
• MOL2-14-1731.pdf
• MOL2-14-1731-s002.xlsx, sheet 1

View BVdb publication page

---

Significant Benefits of Osimertinib Against Adenosquamous Carcinoma Harboring Germline T790M Mutation.

The Oncologist

Huo, Ran R; Li, Jinghua J; Li, Xiaofang X; Shi, Junping J; Wang, Kunjie K; Jiao, Jin J; Shang, Yanhong Y

Publication Date: 2020-10

Variant appearance in text: HER2: V659E

PubMed Link: 32367600

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.

Cancer

Mack, Philip C PC; Banks, Kimberly C KC; Espenschied, Carin R CR; Burich, Rebekah A RA; Zill, Oliver A OA; Lee, Christine E CE; Riess, Jonathan W JW; Mortimer, Stefanie A SA; Talasaz, AmirAli A; Lanman, Richard B RB; Gandara, David R DR

Publication Date: 2020-07-15

Variant appearance in text: ERBB2: V659E

PubMed Link: 32365229

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Mutational landscape and characteristics of ERBB2 in non-small cell lung cancer.

Thoracic Cancer

Wei, Xue-Wu XW; Gao, Xin X; Zhang, Xu-Chao XC; Yang, Jin-Ji JJ; Chen, Zhi-Hong ZH; Wu, Yi-Long YL; Zhou, Qing Q

Publication Date: 2020-06

Variant appearance in text: ERBB2: V659E

PubMed Link: 32291971

Variant Present in the following documents:

• Main text
• TCA-11-1512.pdf

View BVdb publication page

---